Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 98 clinical trials
Acute and Long-Term Antidepressant Treatment Success in Adolescents With Anxiety (AtLAS-A)

Acute, double-blind, adaptively randomized treatment with duloxetine or escitalopram, followed by open-label naturalistic follow-up.

implanon
nuvaring
norplant
panic disorder
progestin
  • 0 views
  • 19 Feb, 2024
The Efficacy and Safety of Different Doses of SY-004 in Patients With Type 2 Diabetes Mellitus

This is a multicenter, randomized, double-blind, placebo-controlled phase II clinical study in patients with type 2 diabetes mellitus (T2DM).

fasting blood glucose
antidiabetic agent
blood glucose self-monitoring
monitors blood glucose
fasting
  • 0 views
  • 19 Feb, 2024
A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects

This is a randomized, single-blind, placebo-controlled, once daily (QD) dose study of CRV431 in presumed NASH F2/F3 subjects.

vcte
fibrosis
fatty liver
fibroscan
hepatic fibrosis
  • 0 views
  • 19 Feb, 2024
A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19

A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of pulsed inhaled iNO compared to placebo in subjects with COVID-19.

treatment regimen
acute respiratory syndrome (sars)
ct scan
nitric oxide
chest x-ray
  • 0 views
  • 19 Feb, 2024
Evaluating the Clinical Value of Traditional Chinese Medicine in the Adjuvant Therapy of Triple-negative Breast Cancer

This is a prospective, single site, randomized, double-blind Phase III clinical trial to evaluate the clinical value of Traditional Chinese Medicine in the adjuvant therapy of triple-negative breast cancer patients.

HER2
immunohistochemistry
creatinine clearance rate
progesterone receptor
blood transfusion
  • 0 views
  • 19 Feb, 2024
A Study to Evaluate the Safety Tolerability and Immunogenicity of Tau Targeted Vaccines in Participants With Early Alzheimer's Disease

This study is a multicenter, double blind, randomized, placebo-controlled study to evaluate the safety, tolerability and immunogenicity of different doses, regimens and combinations of Tau targeted vaccines in participants with early Alzheimer's Disease.

dementia
acetylcholinesterase inhibitor
cognitive impairment
mental state examination
memantine
  • 0 views
  • 19 Feb, 2024
Colloid Co-hydration and Vasoconstrictor Infusion for Prevention of Hypotension During Cesarean Section

This will be a double-blind randomized study, aiming at investigating a fixed rate phenylephrine infusion versus a fixed rate norepinephrine infusion versus placebo in combination with co-hydration with colloids for the prevention of maternal hypotension in elective cesarean section

  • 0 views
  • 19 Feb, 2024
Comparison of Epidural Combined and Dural Puncture Labor Epidural on Pain and Course of Vaginal Delivery

The three standard techniques used for labor analgesia, thus epidural, combined spinal-epidural and dural puncture epidural will be compared regarding their impact on pain intensity, analgesic and local anesthetic consumption and course of vaginal delivery in a prospective, randomised, double blind manner

analgesia
pain relieving
local anesthetics
analgesics
local anesthetic
  • 0 views
  • 19 Feb, 2024
Dexmedetomidine in TAP Block for Inguinal Hernia Repair

This prospective double-blind randomized study will aim at evaluating the short- and long-term postoperative analgesic efficacy of the ultrasound-guided transversus abdominis plane (TAP) block with a combination of local anesthetic and dexmedetomidine in inguinal hernia repair under general anesthesia

transversus abdominis plane block
general anesthesia
inguinal hernia repair
anesthesia
elective surgery
  • 0 views
  • 19 Feb, 2024
Study to Evaluate Patients With Cerebrotendinous Xanthomatosis

The study is made up of two cohorts: a randomized double-blind crossover (placebo withdrawal with rescue) study among patients 16 years of age (adult cohort) and an open-label dose titration study among pediatric patients 1 month and <16 years of age (pediatric cohort)

  • 0 views
  • 19 Feb, 2024